Flow Traders U.S.’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Flow Traders U.S.’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Sell	8,017 -52,251	-87%	-$7.06M	0.05%	353
2026 Q1	$7.7M	Buy	+60,268	New	+$7.52M	0.24%	75
2025 Q3	–	Sell	-2,801	Closed	-$232K	–	1288
2025 Q2	$232K	Sell	2,801 -9,734	-78%	-$777K	0.01%	812
2025 Q1	$1.02M	Buy	+12,535	New	+$1.12M	0.04%	394
2024 Q2	–	Sell	-17,792	Closed	-$1.69M	–	1110
2024 Q1	$1.69M	Buy	17,792 +11,834	+199%	+$1.1M	0.09%	208
2023 Q4	$532K	Buy	+5,958	New	+$442K	0.02%	484
2023 Q2	–	Sell	-36,927	Closed	-$2.81M	–	1125
2023 Q1	$2.81M	Buy	+36,927	New	+$3.06M	0.11%	134
2021 Q3	–	Sell	-4,907	Closed	-$664K	–	1194
2021 Q2	$664K	Buy	+4,907	New	+$645K	0.03%	512
2020 Q4	–	Sell	-17,769	Closed	-$1.98M	–	797
2020 Q3	$1.98M	Sell	17,769 -3,800	-18%	-$426K	0.15%	143
2020 Q2	$2.42M	Buy	+21,569	New	+$2.12M	0.19%	103
2017 Q2	–	Sell	-7,260	Closed	-$503K	–	358
2017 Q1	$503K	Buy	7,260 +269	+4%	+$18.1K	0.04%	206
2016 Q4	$414K	Buy	+6,991	New	+$432K	0.03%	226
2016 Q3	–	Sell	-4,132	Closed	-$223K	–	476
2016 Q2	$223K	Sell	4,132 -100,452	-96%	-$5.5M	0.02%	173
2016 Q1	$5.4M	Buy	+104,584	New	+$5.43M	0.55%	41
2014 Q3	–	Sell	-6	Closed	–	–	225
2014 Q2	$0	Buy	+6	New	+$271	﹤0.01%	240

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Flow Traders U.S.'s XBI Position: Q2 2026 in Review

Flow Traders U.S. reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 87% in Q2 2026, selling an estimated $7.06M and leaving 8,017 shares worth $1.27M. The position accounts for 0.05% of the portfolio, ranked #353.

Flow Traders U.S. first reported a position in XBI in Q2 2014 and has held it in 15 quarters since. The position peaked at $7.7M in Q1 2026. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Flow Traders U.S. held 8,017 shares of State Street SPDR S&P Biotech ETF worth $1.27M as of Q2 2026.
Flow Traders U.S. sold 52,251 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $7.06M.
State Street SPDR S&P Biotech ETF made up 0.05% of Flow Traders U.S.'s portfolio in Q2 2026, its #353 holding.
Flow Traders U.S. first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and has held it in 15 quarters since.
Flow Traders U.S.'s State Street SPDR S&P Biotech ETF position peaked at $7.7M in Q1 2026.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.